Search - tctmd.com

Displaying 81 - 100 of 179

Sort: Relevancy | Date

Presentation

IMPELLA vs Intra-Aortic Balloon PumpA Reflective Perspective

Presenter: David Cox

April 11, 2019

News Daily News

Organ Failure in Patients With Acute MI and Shock Is Prevalent and Rising

Michael O'Riordan

April 08, 2019

News Conference News ACC 2019

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

Caitlin E. Cox

March 16, 2019

News Conference News STS 2019

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Yael L. Maxwell

February 06, 2019

News Daily News

FDA Warns Healthcare Providers of Potential Rise in Death Rate With Impella RP

Caitlin E. Cox

February 04, 2019

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Caitlin E. Cox

December 11, 2018

News Conference News AHA 2018

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

Caitlin E. Cox

November 11, 2018

News Daily News

New Battery, Malfunction Issues Hit Beleaguered IABPs

Todd Neale

November 01, 2018

Presentation TCT Abstracts Posters 2018

Cardiogenic Shock in a 58 Year Old Male with Critical 3 Vessel Disease: Intra-Aortic Balloon Pump (IABP) Stabilizing Hemodynamics to Facilitate Percutaneous Coronary Revascularization

Presenter: Conor Mcquillan

September 25, 2018

Presentation TCT 2018

TCT-81: The Comparative Effectiveness and Safety of Impella Versus Intra-Aortic Balloon Pump in Patients who Underwent Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Presenter: Biswajit Kar, Simon Redwood, Devraj Sukul

September 21, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Daily News

Dedicated Coronary Teams May Be Key to Optimizing CABG Outcomes

L.A. McKeown

July 27, 2018

News Daily News

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

L.A. McKeown

July 03, 2018

News Daily News

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

Caitlin E. Cox

June 07, 2018

News Conference News EuroPCR 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

Caitlin E. Cox

May 31, 2018

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

News Daily News

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

Todd Neale

February 13, 2018

Presentation ISET 2018

Understanding Indication and Management of Short Term Mechanical Circulating Support Including Intra Aortic Balloon Pump and lmpella Device

Presenter: Bernardo Lopez-Sanabria

February 03, 2018

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

Todd Neale

October 02, 2017

News Daily News

IABPs Recalled Due to False Blood Detection Alarms and Ingress of Fluid

L.A. McKeown

September 06, 2017

Advertisement

IMPELLA vs Intra-Aortic Balloon PumpA Reflective Perspective

Organ Failure in Patients With Acute MI and Shock Is Prevalent and Rising

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

FDA Warns Healthcare Providers of Potential Rise in Death Rate With Impella RP

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

New Battery, Malfunction Issues Hit Beleaguered IABPs

Cardiogenic Shock in a 58 Year Old Male with Critical 3 Vessel Disease: Intra-Aortic Balloon Pump (IABP) Stabilizing Hemodynamics to Facilitate Percutaneous Coronary Revascularization

TCT-81: The Comparative Effectiveness and Safety of Impella Versus Intra-Aortic Balloon Pump in Patients who Underwent Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Dedicated Coronary Teams May Be Key to Optimizing CABG Outcomes

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

Understanding Indication and Management of Short Term Mechanical Circulating Support Including Intra Aortic Balloon Pump and lmpella Device

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

IABPs Recalled Due to False Blood Detection Alarms and Ingress of Fluid

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content